Minerva Neurosciences
NERV
82 hedge funds and large institutions have $367M invested in Minerva Neurosciences in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 35 increasing their positions, 16 reducing their positions, and 4 closing their positions.
225% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 4
119% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 16
54% more capital invested
Capital invested by funds: $238M → $367M (+$129M)
12% more funds holding
Funds holding: 73 → 82 (+9)
0.12% more ownership
Funds ownership: 9.3% → 9.42% (+0.12%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$11.1M |
| 2 |
BlackRock
New York
|
+$2.5M |
| 3 |
Millennium Management
New York
|
+$2.46M |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$1.3M |
| 5 |
NLVP
New Leaf Venture Partners
New York
|
+$1.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$16.5M |
| 2 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$3.67M |
| 3 |
JG
Jefferies Group
New York
|
-$1.89M |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$977K |
| 5 |
Franklin Resources
San Mateo,
California
|
-$938K |
NERV Hedge Fund Activity: Q3 2018 in Review
82 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q3 2018, worth a combined $367M — up 54% from $238M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new NERV positions and 4 closed out — a net gain of 9 holders — while 35 added to existing stakes and 16 trimmed.
The largest buyer was Dimensional Fund Advisors, adding an estimated $11.1M. The largest seller was Fidelity Investments, cutting an estimated $16.5M.
- 82 institutional investors held Minerva Neurosciences (NERV) as of Q3 2018, up from 73 in Q2 2018.
- Funds reported $367M of Minerva Neurosciences stock for Q3 2018, up 54% quarter-over-quarter.
- 13 funds opened new Minerva Neurosciences positions in Q3 2018 and 4 closed out, a net change of +9 holders.
- The largest Minerva Neurosciences buyer in Q3 2018 was Dimensional Fund Advisors, an estimated $11.1M added.
- The largest Minerva Neurosciences seller in Q3 2018 was Fidelity Investments, an estimated $16.5M sold.
Based on aggregated 13F filings for Q3 2018.